Invariant chain (Ii) is an important multifunctional player in the regulation of adaptive 31 immune responses and is responsible for several cellular functions related to MHCI and MHCII 32 antigen loading and antigen presentation. While regulating endosomal trafficking of MHCII 33 and other proteins that bind to Ii, this molecule is able to influence the endosomal pathway 34 delaying the maturation of endosomes to the late endosomal loading compartments. When 35 expressed in cells Ii is found to increase endosomal size, but the mechanisms for this is not 36 known. We used RNAi silencing to identify SNARE proteins controlling Ii induced increase 37 of endosomal size and delay of the endosomal pathway. Ii was found to interact with the 38 SNARE protein Vti1b. Vti1b localized at the contact sites of fusing Ii positive endosomes and 39 a tailless Ii was able to relocate Vti1b to the plasma membrane. Furthermore, silencing Vti1b, 40 abrogated the delay in endosomal maturation induced by Ii expression. In conclusion, Ii 41 interacts with Vti1b and this interaction is fundamental for Ii-mediated alteration of the 42 endosomal pathway. We propose that Ii, by interacting with SNAREs, in particular Vti1B in 43 the biosynthetic pathway of antigen presenting cells, is able to assemble SNARE directed 44 fusion partners in the early part of the endosomal pathway that lead to a slower endosomal 45 maturation for efficient antigen processing and antigen loading.
compartments strongly increased (Pieters, Bakke, and Dobberstein 1993; Romagnoli et al. 137 1993) . In fact, there was a direct correlation between the size increase and Ii-expression levels 138 (Nordeng et al. 2002) . Both the delayed maturation and the endosomal expansion was 139 dependent on Ii trimerization and suggested that these effects were caused by the same 140 mechanism (Nordeng et al. 2002; Gregers et al. 2003) . NEM is a chemical compound that 141 block amongst others SNARE proteins. Since NEM inhibited Ii driven effects on the 142 endosomal pathway, we proposed a contribution of SNAREs (Nordeng et al. 2002) . 143
To test for SNAREs involved in Ii-mediated endosome enlargement, we silenced all 144 individual SNAREs in the M1 fibroblast cell line, stably transfected with Ii under the control 145 of a heavy-metal inducible promoter (M1 pMep4-Ii, (Nordeng et al. 2002) ). The M1 wild type 146 cell line is negative for Ii and the MHCII proteins but the cell line has been employed 147 extensively to study endosomal dynamics and antigen presentation by transfecting in immune 148 genes (Roche et al. 1993; Stang and Bakke 1997; Skjeldal et al. 2012; Sand et al. 2014; Haugen 149 et al. 2017) . Ii transport to Ii positive endosomes was visualized by adding fluorescently tagged 150 antibody recognizing the extracellular/luminal domain of Ii, and the size of Ii-positive 151 endosomes was analysed by confocal microscopy (Figure 2A) . 152
As a test for our screening system we employed some of the known inhibitors of early 153 endosome fusion. The MAP kinase inhibitor SB203580 (Cuenda et al. 1995 ) was used to block 154 Rab5 activation and Wortmannin to inhibit PI3K activity (Wymann et al. 1996) . As shown 155 earlier (Nordeng et al. 2002) , wortmannin did not inhibit formation of enlarged endosomes (Fig  156   2B ). MAP kinase activity was also not essential since SB203580 could not stop the formation 6 of SNARE function, significantly reduced Ii-mediated endosome enlargement by about 50% 159 ( Fig 2B) , in line with earlier results from cell free studies (Nordeng et al. 2002) . 160
To screen for specific SNARE proteins involved in Ii-mediated endosome enlargement, 161 inducible M1 pMep4-Ii cells were transfected with pools of siRNAs (four oligos per target 162 gene) targeting 40 individual human SNAREs. Three days post-transfection, cells were 163 analysed by 3D confocal microscopy to determine the degree of endosome enlargement upon 164
Ii expression. This screen showed that silencing Vti1b counteracted the Ii induced endosome 165 enlargement by 50%. Validation with individual siRNAs for Vti1b showed an even stronger 166 inhibitory effect for two out of the four siRNAs ( Fig 2C) . Western blot analyses of cells 167 transfected with these siRNAs confirmed a significantly reduced level of the Vti1b target 168 protein ( Fig 2D-E) . 169
These experiments suggest that depletion of Vti1b inhibits the Ii induced formation of enlarged 170 endosomes. 171 172
Silencing of Vti1b specifically reduces Ii-mediated endosome enlargement 173
Given the effect of Vti1b in the regulation of the size of Ii-positive endosomes, we 174 evaluated whether the depletion of this SNARE also interfered with endosomes enlarged by 175 other means than expression of Ii. A well-known method for expanded early endosomes is to 176 express the active mutant of Rab5 (Rab5Q79L) (Stenmark et al. 1994; Wegner et al. 2010 ). M1 177 pMep4-Ii cells were transfected with control siRNA or siRNA targeting Vti1b and 178 subsequently either treated with CdCl2 to induce Ii expression, (inducible metallothionine 179 promotor) ( Fig 3A, top row) or transfected with EGFP-Rab5Q79L ( Fig 3A, bottom row) . 180
Images were acquired and the size of Ii-or Rab5Q79L-positive endosomes was determined 181 ( Fig 3B) . Silencing of Vti1b with either of the two siRNAs reduced Ii-mediated endosome 182 expansion by approximately 70% (Fig 3B) . On the other hand, Vti1b depletion did not affect 183 the size of Rab5Q79L-positive endosomes, showing that Vti1b is not essential for endosome 184 enlargement of early endosomes induced by active Rab5. To study this process further we 185 quantified the number of endosomes per cell in the above experiment and observed that the 186 silencing of Vti1b significantly increased the number of endosomes after Ii expression ( Fig  187   3C ). On the other hand, silencing of Vti1b had no effect on the number of endosomes after 188 overexpression of Rab5Q79L ( Fig 3C) The above measurements suggest that Vti1b effect is 189 not a general requirement for enlarging early endosomes, but more specific for the Ii induced 190 endosomal expansion. 191
Vti1b localized to contact sites between Ii-positive endosomes during their fusion 193
Given the well documented role of SNARE proteins in membrane fusion, we decided 194 to evaluate the localization of Vti1b in M1 pMep4-Ii cells transfected with mCitrine. Interestingly, cells expressing Vti1b-mCitrine showed that this SNARE protein is 196 localized at the contact sites between Ii-positive endosomes ( Fig 4A, Movie EV1, see also 4B 197 top row for fixed cells). In particular, Vti1b-mCitrine was detected directly at the opening 198 fusion pore between two Ii-positive endosomes ( Fig 4A, Movie EV1 ). Moreover, mCitrine was localized in intense microdomains on endosomes with these domains often found 200 at the contact sites between two Ii-positive endosomes. As a control we used again mCherry-201
Rab5Q79L induced enlarged endosomes ( Fig 4B bottom row) . Quantification of the frequency 202 with which Vti1b localized at the contact sites showed that Vti1b accumulated at about 80% of 203 the contact sites between Ii-positive endosomes whereas Vti1b localized to this contact zone in 204 40% of the recorded interaction sites between Rab5Q79L-positive endosomes ( Fig 4C) . This 205 shows that Vti1b is recruited more often to the contact site of fusing Ii-positive endosomes as 206 compared to Rab5Q79L-positive endosomes ( Fig 4C) . Furthermore, we also evaluated the 207 localization of endogenous Vti1b in M1 pMep4-Ii cells where Ii has been induced and 208 endosomes were enlarged ( Fig 4D) . Similarly, to the transfected Vti1b-mCitrine fusion protein, 209 immunofluorescence of endogenous Vti1b showed its localization at the contact sites of Ii-210 positive endosomes ( Fig 4D) . This was also studied in the Meljuso cells, and again Vti1b 211 localized to contact sites between Ii-positive endosomes ( Fig 4E) , indicating that Vti1b 212 associated with invariant chain at endosomal contact sites also in professional antigen 213 presenting cells. In Meljuso cells the endosomes were not enlarged showing that Vti1b 214 localization was not restricted to Ii induced enlarged endosomes. 215 216
Vti1b interacts with Ii 217
As Vti1b has a role in the regulation of the Ii-mediated endosomal enlargement and 218
colocalize with Ii, we tested, whether this SNARE could interact with Ii. Firstly, we transfected 219 either EGFP (as a negative control) or Vti1b-mCitrine into M1 pMep4-Ii cells. The expression 220 of Ii was induced by CdCl2 treatment overnight and then we performed a co-IP experiment 221 using anti-GFP nanobodies. We evaluated the presence of Ii in the eluates by Western blot (Fig  222   5A ). We observed a band for Ii after immunoprecipitation of Vti1b-mCitrine with anti-GFP 223 antibodies but not for the control EGFP ( Fig 5A) showing that Vti1b interacts with Ii. In order 224 to further elucidate the interaction between Vti1b and Ii, we transfected Vti1b-mCitrine and 225 used cells co-transfected with EGFP and Ii wt. Then we performed a co-immunoprecipitation 227 assay with anti-GFP nanobodies ( Fig 5B) . Interestingly, Vti1b-mCitrine interacted with full-228 length Ii but also with Ii∆27 ( Fig 5B) , showing that the cytoplasmic tail of Ii is dispensable for 229 binding to Vti1b. To characterize the localization of these two associated proteins, we expressed the 237 tailless Ii with a hexahistidine tag, (His-Ii Δ27) and Vti1b-mCitrine in HeLa cells and as control 238 the same set up with full length Ii. As shown in Figure 6 , Vti1b with full-length Ii was located 239 in intracellular vesicles including endosomes positive for Ii. However, when Vti1b was 240 expressed with Ii Δ27, a large fraction of Vti1b colocalized with Ii Δ27 at the PM. Since Vti1b 241 was found to bind both Ii wild type and Ii Δ27, this suggest that these two molecules are 242 associated in the biosynthetic pathway and that Vti1b is actively sorted by Ii to the endosomal 243 pathway. 244
245
The influence of Ii KO on Vti1b distribution in antigen presenting cells. 246
In the intracellular trafficking experiments above we transfected Ii and mutants into 247 cells lacking MHCII and associated genes (M1 and Hela cells). Meljuso cells, however, express 248 endogenously the proteins involved in MHCII loading including MHCII, Ii and HLA-DM 249 (Elliott and Neefjes 2006) . MHCII may change the activities of Ii on endosomal maturation 250 and expansion. To test this, we transfected Vti1b-mCitrine into Meljuso Ii KO and Meljuso wt 251 cells followed by fixation and labelling with anti-CI-M6PR antibody that labels trans-Golgi 252 network (TGN) and endosomes (Fig 7) . Interestingly, Vti1b-mCitrine colocalized more with 253 CI-M6PR in the Ii KO cells as compared with the wild type ( Fig 7A, for quantitation, Figure  254 7B). We also evaluated the number of vesicles positive for Vti1b-mCitrine which was 255 drastically reduced with about 40 vesicles/cell in the Ii KO cells as compared an average of 256 240 vesicles/cell for the wild type ( Fig 7C) . The volume of the CI-M6PR positive structures, 257 in the Ii KO and wild type Meljuso cells were not significantly different ( Fig 7D) . As shown 258 in Figure 7 we were able to rescue the phenotype by transfecting cDNA for Ii into the KO cells 9 indicating that the altered intracellular distribution of Vti1b is indeed caused by the Ii KO and 260 not by an off target effect. 261
The CI-M6PR localizes in the trans-Golgi, plasma membrane and the late endosomal 262 pathway (Hille-Rehfeld 1995) . To firmly establish the localization of Vti1b in the Meljuso Ii 263 KO, we also colocalized Vti1b with the Golgi resident protein giantin (Linstedt and Hauri 264 1993) and with TGN46 which mainly resides in the TGN (Prescott et al. 1997) . As shown in 265 Ii cells after induction with CdCl2 ( Fig EV2F) did also not affect Vti1b expression ( Fig EV2) . 283
Ii expression does not affect endogenous Vti1b expression. 284 285

Knockdown of Vti1b does not affect lysosome dynamics and expression of endosomal 286 marker proteins 287
Vti1b is reported to be a SNARE mainly involved in the late steps of endocytosis 288 (Antonin et al. 2000; Pryor et al. 2004; Luzio et al. 2009; Kreykenbohm et al. 2002) and we 289 wondered whether Vti1b knock down could affect the expression of other proteins relevant in 290 the endosomal pathway (Rab7a, Rab7b, Rab9, LAMPI and EEA1, see Fig EV3) . Western blot 291 analysis revealed that the expression level of these endosomal proteins was unaltered after 292
Vti1b depletion ( Fig EV3B-F) . In addition, we were also unable to detect significant alterations Invariant chain associates with MHCII and the first function to be described was its 314 ability to sort MHCII molecules to intracellular endosomal compartments. It was later shown 315 that Ii actively sort other molecules to the endosomal pathway such as CD1 and MHCI, both 316 molecules that participates in antigen presentation to specific T cells (for reviews see (Neefjes 317 et al. 2011) and (Schroder 2016)). Other striking trafficking features of Ii is that, when 318 expressed in non-antigen-presenting cells, it delays endosomal maturation (Gorvel et al. 1995; 319 Landsverk et al. 2011 ). In addition, Ii has "fusogenic" properties as expression in cells lead to 320 homotypic fusion of early endosomes (Nordeng et al. 2002; Romagnoli et al. 1993; Stang and 321 Bakke 1997) . This had led to the hypothesis that Ii is a key immunological molecule that is 322 essential for creating "immunoendosomes" suitable for slowly processing endosomal contents shown between the Ii induced formation of enlarged early endosomes and Ii induced maturation 331 delay, however, mutations of the charged residues from negative to positive in the cytosolic 332 tail of Ii has been found to abrogate both effects without altering the leucine sorting signals 333 (Gregers et al. 2003; Nordeng et al. 2002) indicating that both effects are caused by similar 334 mechanisms. 335
How would Ii manipulate the endosomal pathway? We have shown by NMR studies 336 that the cytosolic tails of invariant chain could interact in trans and possibly interact in 337 homotypic fusion (Motta et al. 1997 ). Ii has a short cytosolic tail of 30 aa, which would prevent 338 it as acting as a genuine SNARE. It is thus more likely that other molecules are recruited to Ii 339 to manipulate the endosomal pathway. We showed earlier that EEA1 or Rab5 were not essential 340 for the Ii induced fusion and resulting enlargement of endosomes (Nordeng et al. 2002) . 341
However, the chemical compound NEM, that inhibits the SNARE function blocked fusion and 342 formation of Ii induced enlarged endosomes (Nordeng et al. 2002) , bringing our attention to 343 SNAREs as essential for the process. We confirmed this data in the system that we used for the 344 screen ( Fig. 2B) . 345
Based on these data we performed an RNAi screen to search for specific SNAREs that 346 were essential for the Ii induced endosomal fusion. In our RNAi screen, we found that silencing 347 of the Qb SNARE, Vti1b strongly decreased Ii-induced endosomal size (Fig 2C-E) . 348
Interestingly, although Vti1b has a major role in the fusion of late endosomes, it has not been 349 implicated in the fusion of early endosomes (Luzio et al. 2009; Pryor et al. 2004; Kreykenbohm 350 et al. 2002; Antonin et al. 2000) . This shows that Ii employs a SNARE complex that is 351 independent of the canonical early endosomal fusion machinery and can act in parallel. 352
In support of this, enlargement of endosomes induced by the expression of the constitutively 353 active mutant of Rab5, Rab5Q79L, was not affected by Vti1b silencing (Fig 3) . Interestingly, 354 the reduction of Ii-positive endosomal size was accompanied by an increase in the number of 355
Ii-positive endosomes, corroborating the hypothesis that Ii-induced enlargement of endosomes 356 is due to an increase in endosomal fusion rather than reduced fission. 357
In support of this data, we demonstrated that both overexpressed and endogenous Vti1b 358 was localized at the contact sites of Ii-positive endosomes in different cell lines and especially 12 Strikingly, the effect was highly pronounced for the Ii-enlarged endosomes and Vti1b was 361 detected at 80% of the endosome-endosome contact points. Using another method that enlarges 362 endosomes, the constitutive active Rab5 (Rab5Q79L) (Wegner et al. 2010) , Vti1b was only 363 seen in 40% of the contact sites. This indicates that Vti1b is located at the site where fusion is 364 happening and invariant chain expression then affects the location of Vti1b. 365
Immunoprecipitation studies showed that Vti1b binds to Ii, directly or indirectly and this 366 interaction may be the reason for the presence of Vti1b in the contact zone between Ii-positive 367 endosomes. The fact that tailless Ii (Ii 27) also co-isolated Vti1b, suggests that the interaction 368 is via their transmembrane domains or indirect. 369
The antigen presenting cell line Meljuso expresses Ii, and we find that the distribution 370 of Vti1b was shifted perinuclear in the Ii KO cells showing an increased colocalization with 371 CI-M6PR, Giantin and TGN46 (Fig. 7,8) , which all are located mainly at the Golgi and 372 correspondingly fewer Vti1b-positive vesicles were detected in Ii KO cells (Fig. 7) . This 373 suggest that Ii in wt Meljuso cells is involved in transport of Vti1b to the endosomal pathway. . We now suggest that Vti1b, due to its interaction with Ii, in antigen-presenting cells 381 is sorted to the early endosomal pathway and thus participates in controlling endosomal 382 maturation and fusion. As silencing of Vti1b leads to less endosomal fusion, we may also 383 postulate that the Vti1b is instrumental for the Ii induced endosomal fusion (Nordeng et al. 384 2002; Romagnoli et al. 1993; Stang and Bakke 1997) . 385 We here show that both the fusogenic properties of Ii and the maturation delay depend 386 on the presence of Vti1b as silencing Vti1b corrected the Ii induced maturation delay in M1 387 cells. In this case, increased fusion mediated by Ii and the SNARE Vti1b and possibly other 388 interactors on early endosomes would lead to a prolonged EE phase. Ii is also found to delay 389 protein proteolysis (Gregers et al. 2003; Landsverk et al. 2011 ) and the part of the endosomal 390 pathway that is trafficked by invariant chain would then create an ideal pathway for 391 proteolytically processing instead of rapidly degrading antigenic proteins for MHC antigen 392 loading of both MHCI, MHCII and CD1 that all associate with Ii. 393 indirectly Vti1b for transport to endosomes, where can then engage in trans-SNARE complex 395 formation. Higher degree of endosomal fusion dependent on a relocation of the "late" SNARE, 396
Vti1b to early endosomes prolongs the EE phase and leads to a slower maturation creating a 397 less proteolytic endosomal pathway. The model further postulate that as Ii positive endosomal 398 vesicles engage in homotypic fusion, then not only Ii but also the associated molecules like 399 MHCII will be concentrated in some late endosomal/lysosomal vesicles as in the MIIC 400 compartment (Peters et al. 1991). 401 It is very interesting that the expression of a single protein, in this case Ii, a protein 402 specific to antigen-presenting cells has the ability to reshape the endosomal pathway in a 403 specific way. Our results support the notion that Ii not only increases the fusion of early 404 endosomes by employing the late endosomal Qb-SNARE Vti1b but also affects endosomal 405 maturation. Therefore, Ii is not only chaperoning MHCII to the loading compartment (MIIC), 406 but is also involved in shaping this specialized organelle of professional APCs. The MIIC has 407 a unique proteolytic environment, less aggressive than that of classical lysosomes (Neefjes 408 1999) which is needed for efficient but not full processing of antigens. We suggest that this 409 property is intricately connected to Ii's ability of delaying endosomal maturation. In addition, 410 the antigen loading compartments integrate antigen input from several other sources than 411 endocytosis, such as phagocytosis, macropinocytosis and autophagy (Blum, Wearsch, and 412 Cresswell 2013), but whether the transfer of these to the immunoendosome is by a general or 413 a more specific mechanism is not known. 414
In conclusion, we show here that the Qb SNARE Vti1b is involved in Ii-mediated 415 endosomal fusion. Ii redistributes Vti1b from the Golgi to early endosomes, which leads to 416 increased fusion and also delayed maturation of endosomes. This mechanism of regulating 417 endosomal fusion could be critical for efficient MHCI and II antigen presentation and thus 418 normal immune responses. 419 420 421 422 For the siRNA screen, imaging was performed on an Olympus FV1000 XV81 confocal laser 533 scanning microscope (inverted) equipped with a UPLSAPO 60x 1.35NA oil immersion 534 objective. Images of cells transfected with individual siRNAs were acquired on a Leica SP8 535
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DMi8-CS confocal microscope equipped with a HC PL Apo 40x 1.3NA oil immersion 536 objective. 537
Live imaging of transfected cells and imaging of immunostained cells was performed on a 538
Zeiss LSM880 microscope equipped with a Plan Apo 63x 1.4NA oil immersion objective. Live 539 cells were imaged using Fast AiryScan mode with optimal sampling for super-resolution. 540
Time-lapse imaging to study the trafficking of HPTS to acidic compartments was performed 541 on a Zeiss LSM880 microscope, equipped with a Plan Apo 40x 1.3NA oil immersion objective. 542 Z stacks of 5 slices each were acquired at intervals of 1 µm every 10 min for a total of 200 min 543 at multiple positions. Hardware-based autofocusing (DefiniteFocus.2) was performed at every 544 position and every time-point. Fluorescence emission of HPTS and LTR was separated by 545 linear unmixing based on reference spectra obtained from single stained samples. 546 547
Image processing and analysis 548
Endosome size was quantified by using ImageJ software. In brief, confocal 3D stacks were 549 maximum projected, in case of EGFP-Rab5Q79L images, the cytosolic background was 550 subtracted by rolling ball background subtraction. The resulting images where then binarized 551 by using a manually adjusted threshold for each image. After that, the images were inverted, 552 morphologically opened, objects split by watershed processing and manual splitting where 553 needed. Finally, the analyse particles function was used to measure all objects. The Feret's 554 diameter was used as the measurement of object size and objects larger than 3 µm were 555 considered enlarged endosomes. 556 LTR colocalization was quantified using the colocalization function in ZEN blue software 557 (Zeiss). In brief, scatter plots were used to define thresholds on the centre z slice for each 558 position. The ratio of overlapped pixels to all LTR-positive pixels was then calculated for all 559 slices of a z stack, summed for each position and compared between conditions using excel Immunoblotting 563
Cell lysates were subjected to SDS-PAGE followed by blotting onto polyvinylidene fluoride 564 (PVDF) membranes (Millipore), and probed with each primary antibody diluted in 2% blotting-565 grade non-fat dry milk (BioRad). Next, membranes were incubated with secondary antibodies 566 conjugated to HRP and subsequently with SuperSignal West Femto Maximum Sensitivity 567 Substrate (Thermo Fisher) before digital imaging (Kodak image station 4000R) or 568
Amersham™ ECL Prime Western Blotting Detection Reagent before exposure on 569
Amersham™ Hyperfilm ECL (both GE Healthcare). 570 571
Statistical analysis 572
If not indicated otherwise, columns and error bars represent the mean ± standard error of the 573 mean (s.e.m.) of at least three independent experiments. Treatments were compared to control 574 using two-tailed Student's t-test, either paired or unpaired as appropriate (excel). Differences 575 were considered statistically significant at p<0.05 (indicated by *), p<0.01 (**) and p<0.001 576 (***), respectively. 577 578
Co-Immunoprecipitation 579
Co-Immunoprecipitation experiments using GFP-trap® (ChromoTek) were performed 580 according to manufacturer's protocol. In brief, 1-2x10 6 cells were seeded on 10 cm cell culture 581 dishes and incubated for 24 h at 37°C, 5% CO2. The cells were then transfected using 582
Lipofectamine 2000 as described earlier. M1 pMep4-Ii cells were treated with 7 µM CdCl2 583 overnight to induce expression of Ii. Cells were washed twice with ice-cold PBS and lysed in 584 200 µl lysis buffer (100 mM NaCl, 1 mM EDTA, Complete® protease inhibitors (Sigma), 1 585 mM PMSF (Phenylmethylsulfonylfluorid, Sigma), 0.5% NP-40) for 30 min on ice. Lysates 586 were cleared by centrifugation at 13,000 x g for 10 min at 4°C, diluted with 300 µl buffer and 587 loaded on magnetic agarose anti-GFP beads (GFP-trap®_MA, ChromoTek) for 1 h at 4°C. 588
Beads were then washed three times. Proteins were eluted using 2x Laemmli sample buffer 589 with freshly added D-thiotreitol (200 mM, Sigma) for 10 min at 95°C. 
